Expanded Access Protocol for Subjects Previously Treated With Gedatolisib in B2151009 Read more about Expanded Access Protocol for Subjects Previously Treated With Gedatolisib in B2151009
Two Intermediate Expanded Access Protocols (EAP) CNMAu8.EAP01 and CNMAu8.EAP02 for ALS Read more about Two Intermediate Expanded Access Protocols (EAP) CNMAu8.EAP01 and CNMAu8.EAP02 for ALS
Dizal Pharmaceutical Co., Ltd By efain on Thu, 02/24/2022 - 12:50 Read more about Dizal Pharmaceutical Co., Ltd
Substance Use Disorders Learn how the Reagan-Udall Foundation for the FDA supports strategies to prevent, treat, and manage substance use disorders by engaging stakeholders and addressing critical gaps in the SUD treatment system. Read more about Substance Use Disorders
